About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Updates on Tumor - Agnostic Treatment Approaches and Biomarker Testing
Updates on Tumor - Agnostic Treatment Approaches and Biomarker Testing
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
V
Updates and Management of Medullary Thyroid Cancer: Genetic Testing for Patients With MTC
By
Penn Medicine Abramson Cancer Center
FEATURING
Virginia Livolsi
,
Katherine Nathanson
,
Lova L. Sun
,
Rachel Kelz
,
Susan Mandel
By
Penn Medicine Abramson Cancer Center
FEATURING
Virginia Livolsi
,
Katherine Nathanson
,
Lova L. Sun
,
Rachel Kelz
,
Susan Mandel
275 views
March 7, 2022
0 Comments
Login to view comments.
Click here to Login
Updates on Tumor - Agnostic Treatment Approaches and Biomarker Testing
11:09
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib &…
Feat.
Y. Nakamura
06:58
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "The Primary Endpoint Analysis of the Phas…
Feat.
H. Akamatsu
04:14
ecancer
ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fiel…
Feat.
T. Leal
25:35
Total Health
NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing
Feat.
S. Kazmi
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
16:29
2023 Texas Lung Cancer Conference Coverage
How to Incorporate Liquid Biopsy for NSCLC in Practice
Feat.
L. Raez
15:57
Rush University Medical Center
Precision Medicine in Pancreatic Cancer: Treatment to Screening
Feat.
F. Bishehsari
20:57
Paul Hofman
Updates in Precision Approaches to the Molecular Diagnosis of NSCLC
14:11
Lorenzo Belluomini
Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray A…
01:01
Lorenzo Belluomini
Lecture Summary - Selpercatinib in RET Fusion-Positive mNSCLC: Achie…
40:27
MedNews Week
Advances in Matching Patients After NGS for Personalized Cancer Ther…
Feat.
R. Kurzrock
10:16
Eric Singhi
Testing for Targetable Mutations in NSCLC: Tissue vs. Liquid Biopsy
43:20
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Biomarker-Targeted Therapies in GI Cancers
Feat.
V. Subbiah
27:37
Total Health
Cancer Diagnostics in GI: Gene Panels, Liquid Biopsy, and Genetics
Feat.
A. Magliocco
14:27
ecancer
Latest in Lung Cancer Genomic Testing
Feat.
S. Popat
07:20
ASCO GI 2023 Conference Coverage
ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurr…
Feat.
R. Mehta
58:12
Moffitt Cancer Center
RET Altered Thyroid Cancer
Feat.
S. Agosto Salgado
54:49
Penn Medicine Abramson Cancer Center
Updates and Management of Medullary Thyroid Cancer: Genetic Testing …
Feat.
V. Livolsi,
K. Nathanson,
L. L. Sun,
R. Kelz,
S. Mandel
